Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M.tuberculosis killing efficiency.
Graphene oxide
Macrophage targeting
Mannose receptor
Mycobacterium tuberculosis
Rifampicin delivery
Journal
Materials science & engineering. C, Materials for biological applications
ISSN: 1873-0191
Titre abrégé: Mater Sci Eng C Mater Biol Appl
Pays: Netherlands
ID NLM: 101484109
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
09
04
2018
revised:
23
04
2019
accepted:
19
05
2019
entrez:
28
7
2019
pubmed:
28
7
2019
medline:
31
12
2019
Statut:
ppublish
Résumé
Tuberculosis (TB), caused by M.tuberculosis (Mtb), has become a top killer among infectious diseases. Enhancing the ability of anti-TB drugs to kill intracellular Mtb in host cells remains a big challenge. Here, an innovative nano-system was developed to increase drug delivery and Mtb-killing efficacy in Mtb-infected macrophages. We employed mannose surface decoration to develop mannosylated and PEGylated graphene oxide (GO-PEG-MAN). Such nano-platform exhibited increased uptake by macrophages via mannose receptor-mediated endocytosis in vitro. Interestingly, drug-loaded GO-PEG-MAN was preferentially up-taken by mannose receptor-expressing mucosal CD14
Identifiants
pubmed: 31349400
pii: S0928-4931(18)31032-4
doi: 10.1016/j.msec.2019.109777
pii:
doi:
Substances chimiques
graphene oxide
0
Graphite
7782-42-5
Mannose
PHA4727WTP
Rifampin
VJT6J7R4TR
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109777Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.